Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Biocon Limited ( (IN:BIOCON) ) has shared an announcement.
Biocon Limited has announced the scheduling of an Extraordinary General Meeting (EGM) on December 31, 2025, to be conducted via video conferencing in compliance with regulatory guidelines. This meeting is significant for stakeholders as it reflects Biocon’s commitment to transparency and adherence to corporate governance standards, potentially impacting its operational strategies and investor relations.
More about Biocon Limited
Biocon Limited is a prominent player in the biopharmaceutical industry, primarily engaged in the development and manufacturing of innovative and affordable biosimilars, generic formulations, and novel biologics. The company focuses on healthcare solutions that address chronic diseases such as diabetes, cancer, and autoimmune conditions, aiming to enhance global healthcare access.
Average Trading Volume: 136,771
Technical Sentiment Signal: Strong Buy
Current Market Cap: 524.2B INR
Learn more about BIOCON stock on TipRanks’ Stock Analysis page.